Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 2 hours 53 min ago

Lynparza now available on Cancer Drugs Fund

26/07/2019
The treatment reduces the risk of disease progression or death in such patients by 70% vs placebo.

CHMP recommends five new medicines

26/07/2019
Stelara, Keytruda and Tecentriq were also among the extensions of therapeutic indication.

£20m investment to help young people find NHS careers

25/07/2019
The funding will support 10,000 young people from all backgrounds to get a career in the NHS.

GSK Q2 figures boosted by vaccine sales

25/07/2019
The company has readjusted its prediction for its earnings per share to decline in the range of -3% to -5% at CER, as opposed to the previous -5% to -9%.

NICE to form alliance to produce chronic asthma guideline

25/07/2019
The guideline aims to support health professionals in making accurate diagnoses and providing effective treatments.

Advanz, Morningside, Alliance accused of illegal market sharing 

25/07/2019
The CMA alleges that Alliance Healthcare bought equal volumes of nitrofurantoin from the companies to discourage competing.

AZ’ roxadustat successful in late-stage trial

25/07/2019
The trial met its primary efficacy endpoint of a mean change in haemoglobin from baseline averaged over weeks 23-27.

Gilead licenses respiratory, herpes antiviral research programs from Novartis

24/07/2019
The antivirus programs include investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses.

NICE reveals ‘health technology evaluation methods’ review

24/07/2019
The review will cover NICE’s technology appraisals, highly specialised technologies, medical technologies, and diagnostics assessment programmes.

Promising early data for MSD’s investigational HIV drug

24/07/2019
The company is also exploring several potential options for PrEP, including a drug-eluting implant and a once-monthly oral formulation.

Pfizer’s Rituxan biosimilar bags FDA approval

24/07/2019
The treatment has been approved in adult patients with non-Hodgkin’s lymphoma.

First UK medical cannabis clinic launched by specialist doctors

24/07/2019
The clinic will offer access to medicinal cannabis for all conditions acknowledged to benefit from it.

UPDATE: Animal testing hits lowest figures since 2007

24/07/2019
New Home Office statistics show a decrease of 7% on last year, and the lowest number of procedures since 2007.

Same-day pharmacy consultations could ‘help relieve GP pressures’

23/07/2019
The service will offer local pharmacy appointments to anyone calling NHS 111 about the minor conditions, such as earache or a sore throat.

Flow raises $1.5m for depression treatments

23/07/2019
The treatment combines clinical psychology, neuroscience and innovative technology including machine learning.

AI used to help diagnose and treat birdshot uveitis

23/07/2019
The Fight for Sight funded project uses AI to extract ‘hidden’ information from retinal images of patients with the rare eye condition.

New gene test could single out cancer patients eligible for ‘targeted nuclear medicine’

23/07/2019
Testing men for faults in DNA repair genes in their tumours could identify those most likely to respond to the new type of treatment.

‘Ground-breaking’ service to help treat AF patients at risk of stroke

23/07/2019
The Oberoi SPAF & Case Finding Service ensures high-risk AF patients receive oral anti-coagulants, helping prevent strokes.

Finalists give their thoughts on the Medical & Scientific Excellence Awards

23/07/2019
The PharmaTimes Medical & Scientific Excellence Awards have been praised by last year’s finalists on it’s great learning and development process.

Mallinckrodt, Silence Theraputics to commercialise RNAi therapeutics

22/07/2019
The agreement provides Mallinckrodt with an exclusive worldwide license for C3 (SLN500) - a preclinical asset that targets a specific protein in the complement pathway.

Pages

X